Abstract
The availability of asthma biologics may not benefit all patients equally. To our knowledge, asthma biologic prescription rates, and adherence in relation to prescribing, have not been previously reported.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
